Results 1 to 10 of about 25,753 (298)

Case report: Successful treatment of refractory membranous nephropathy with telitacicept

open access: yesFrontiers in Immunology, 2023
Despite various treatment methods, the remission rate of membranous nephropathy remains limited. Refractory membranous nephropathy especially lacks effective treatment plans. Telitacicept achieves comprehensive inhibition of CD20-positive B cells, plasma
Hua Jin
exaly   +3 more sources

Anti-glomerular basement membrane disease superimposed on membranous nephropathy: a case report and review of the literature [PDF]

open access: yesJournal of Medical Case Reports, 2010
Introduction Anti-glomerular basement membrane disease is a rare autoimmune disorder characterized by pulmonary hemorrhage, crescentic glomerulonephritis and the presence of circulating anti-glomerular basement membrane antibodies.
Nivera Noel   +2 more
doaj   +2 more sources

Obinutuzumab after anti-rituximab antibody-associated treatment failure in membranous nephropathy: a case report [PDF]

open access: yesFrontiers in Immunology
Rituximab is an established therapy for primary membranous nephropathy, but anti−rituximab antibodies (ARA) have been associated with rituximab treatment failure.
Jianying Guo   +7 more
doaj   +2 more sources

The role of TOMM20 in Mediating TERT translocation to mitochondria and its impact on mitophagy in membranous nephropathy [PDF]

open access: yesBMC Nephrology
Background In idiopathic membranous nephropathy (MN)—now a leading glomerular cause of end-stage kidney disease—mitochondrial quality control via mitophagy is increasingly recognized as a determinant of podocyte fate, yet the molecular switches governing
Limiao Yang   +10 more
doaj   +2 more sources

Primary Membranous Nephropathy With Enhanced Staining of Exostosin 1/Exostosin 2 in the Glomeruli: A Report of 2 Cases

open access: yesKidney Medicine, 2021
Technological advances have allowed the discovery of 6 subtypes of membranous nephropathy based on target antigens: M-type phospholipase A2 receptor (PLA2R), thrombospondin type 1 domain-containing 7A (THSD7A), neural epidermal growth factor-like 1 ...
Takamasa Iwakura   +7 more
doaj   +1 more source

The Efficacy of Rituximab in the Treatment of Membranous Nephropathy

open access: yesJournal of Nepal Health Research Council, 2021
Rituximab is a chimeric monoclonal antibody directed against the CD20 expressed on B cells, originally used to treat lymphoma but is increasingly used for the treatment of autoimmune diseases.
Ruby Maharjan   +2 more
doaj   +1 more source

The value of repeat kidney biopsy during an atypical course of membranous nephropathy

open access: yesBMC Nephrology, 2022
Background The clinical trajectory for patients with primary membranous nephropathy ranges widely from spontaneous remission to a rapid decline in kidney function.
Sumaiya Ahmed   +5 more
doaj   +1 more source

Phospholipase A2 receptor (PLA2R) related membranous nephropathy - not specific for idiopathic cases any more [PDF]

open access: yesJournal of Nephropathology, 2018
Context: Membranous nephropathy is among the most common causes of nephrotic syndrome in adults. Evidence Acquisitions: PubMed, EBSCO, Web of Science, directory of open access journals (DOAJ), EMBASE, and Google Scholar with keywords of phospholipase A2 ...
Bahar Bastani
doaj   +1 more source

Alternative Pathway Dysregulation and the Conundrum of Complement Activation by IgG4 Immune Complexes in Membranous Nephropathy [PDF]

open access: yes, 2016
Membranous nephropathy (MN), a major cause of nephrotic syndrome, is a non-inflammatory immune kidney disease mediated by IgG antibodies that form glomerular subepithelial immune complexes.
Dorin-Bogdan Borza
core   +4 more sources

Rapid diagnosis of membranous nephropathy based on serum and urine Raman spectroscopy combined with deep learning methods

open access: yesScientific Reports, 2023
Membranous nephropathy is the main cause of nephrotic syndrome, which has an insidious onset and may progress to end-stage renal disease with a high mortality rate, such as renal failure and uremia.
Xueqin Zhang   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy